The efficacy and safety of direct acting antiviral treatment and clinical significance of drug-drug interactions in elderly patients with chronic hepatitis C virus infection
Author:
Affiliation:
1. Medizinische Klinik 1; Universitätsklinikum Frankfurt; Frankfurt am Main Germany
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13769/fullpdf
Reference31 articles.
1. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010;Lozano;Lancet,2012
2. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm;Razavi;J Viral Hepat,2014
3. Hepatitis C treatment in the elderly: new possibilities and controversies towards interferon-free regimens;Vespasiani-Gentilucci;World J Gastroenterol,2015
4. Efficacy and safety of interferon treatment in elderly patients with chronic hepatitis C in Japan: a retrospective study using the Japanese Interferon Database;Sato;Hepatol Res,2015
5. Sofosbuvir and ribavirin in HCV genotypes 2 and 3;Zeuzem;N Engl J Med,2014
Cited by 75 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comorbidities and Contraindicated Medications in Patients with Chronic Hepatitis C Infection in Japan: a Real-World Database Study;Kanzo;2024-08-01
2. Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly people;Minerva Medica;2024-06
3. Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey;The Turkish Journal of Gastroenterology;2022-10-06
4. Drug–drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study;Hepatology International;2022-09-08
5. Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients;The Eurasian Journal of Medicine;2022-06-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3